FDA Investigator Jazmine N Brown
Jazmine N Brown has inspections in 2 countries as of 12 Dec 2023. Jazmine N Brown has collaborated with a combined 1399 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
15
Last Inspection Date:
12 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
India
Co-Investigator(s):
Akilah K Green,
Alan P Kurtzberg,
Alice S Tsao,
Amy N Chen,
Anita R Michael,
Anna M Brannen,
Avital A Shimanovich,
Bijoy Panicker,
Brian J Ryan,
Carl E Lovrich,
Charanjeet Jassal,
Charisse K Green,
Craig D Zagata,
Daniel J Mechenbier,
Dipesh K Shah,
Dr. Robert C Horan, MD,
Edmund F Mrak, Jr,
Elaine E Gilfillan,
Erica L Nicoll,
Erika E Englund, PhD,
Erin L Nagel,
Felix Maldonado,
Gary J Lehr,
Gayle S Lawson,
Gregory E Beichner,
Harry J Brewer,
Helen B Ricalde,
James A Liubicich,
James D Bridges,
James M Mason,
Jazmine N Still,
Jessica S Estriplet,
John A Podsadowski,
Johnna L Bleem,
Joseph A Piechocki,
Joseph J Vannelli,
Josh Renzon Ramilo,
Juanita P Versace,
Junho Pak,
Karen L Kosar,
Kathleen M Jordan,
Kejun Cheng,
Kendra L Brooks,
Kevin A Gonzalez,
Kim M Downing,
Lata C Mathew, PhD,
Lauren N Howard,
Lawrence W Farina,
Linda M Sacco,
Lisa B Orr,
Marcellinus D Dordunoo,
Mary R Kirker,
Matthew D Schnittker,
Meisha R Sampson,
Meisha Waters,
Michael A Charles,
Michael L Casner,
Michael W Burd,
Mindy M Chou,
Parul M Patel,
Patrick C Klotzbuecher,
Paul Mouris,
Rajiv R Srivastava,
Roger F Zabinski,
Russell J Glapion,
Saied A Asbagh,
Santos E Camara,
Sarah A Meehan,
Sarah A Wangseng,
Shari L Kahn,
Simone E Pitts,
Sony Mathews,
Susant Hadman,
Tamara L Ely,
Thomas E Friel,
Thomas J Mooney,
Travis R Hunt,
Vlada Matusovsky,
Wayne D Mcgrath,
Wendy G Tan, PhD,
William J Leonard,
Zhongren Wu
Jazmine N Brown's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more